Trial record 10 of 17 for:    Sandhoff Disease

Biomarker for GM1/GM2 - Gangliosidoses (BioGM1BioGM2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02298647
Recruitment Status : Active, not recruiting
First Posted : November 24, 2014
Last Update Posted : July 3, 2018
Centogene AG Rostock
Information provided by (Responsible Party):
Prof. Dr. Arndt Rolfs, University of Rostock

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : July 2018
  Estimated Study Completion Date : July 2018